Device Trial Radar · NCT02777528
Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1
Last checked: Nov 20, 2026Latest source record: Sep 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
79
Actual
Start
Aug 2016
Primary completion
Mar 2024
Study completion Mar 2028
Sponsor
- Lead sponsor
- W.L.Gore & AssociatesNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 19, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to determine whether the GORE® TAG® Thoracic Branch Endoprosthesis is safe and effective in treating lesions of the aortic arch and descending thoracic aorta.
Conditions
- Aortic Aneurysm, Thoracic
- Aorta, Lesion
Interventions
GORE® TAG® Thoracic Branch EndoprosthesisDevice
Endovascular repair with the TBE Device
Revascularization ProcedureProcedure
Revascularization procedure of the great vessel
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Participants With Primary Endpoint Success Through 1 Month for Zone 0/1Time frame: 1 month
- Proportion of Participants With Primary Endpoint Success Through 12 Months for Zone 0/1Time frame: 12 months
Locations
39 sites in 2 countries. Site status is shown where the registry gives one.
Keck Medical Center of USC
Los Angeles, California
Cedar-Sinai Medical Center
Los Angeles, California
Leland Stanford Junior University
Stanford, California
36 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.